Lansoprazole Capsule, Delayed Release
Product Images NDC 71335-1820

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 71335-1820). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1.jpg (Figure 1)

This is a chart that shows the mean severity of heartburn for evaluable patients by study day. The severity is measured on a scale of 0 to 3, with 3 being severe and 0 being none. The chart includes data for a placebo group, as well as groups taking either 15mg or 30mg of Lansoprazole once daily. The data is shown for study days 18, 20, and 25, with percentages calculated for each severity level.*

FDA Label Image

Figure-2.jpg (Figure 2)

This is a table showing the mean severity of night heartburn for evaluable patients over different study days. The severity is rated on a scale of 0 to 3, where 0 represents no heartburn and 3 represents severe heartburn. The table includes data for a placebo group and two treatment groups receiving different doses of lansoprazole. The data is presented graphically using percentages and days from the start of treatment.*

FDA Label Image

Formula-structure.jpg (Image 01)

FDA Label Image

Label (Lbl713351820)

This appears to be a medication label for Lansoprazole, a white capsule with a strength of 30mg. It is recommended to store the medication at room temperature and keep it away from children. The label includes details such as the manufacturer, batch number, and expiry date.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.